Effects of Different Losartan Combination Antihypertensive Therapy in CKD Patients - MIDLAND-CKD Study

agoya University CKD Clinical Cooperation System Study Group0 个研究点目标入组 120 人开始时间: 2010年8月18日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients whose serum creatinine was 2 mg/dL or greater within three months or patients whose eGFR were less than 30 mL/min/1.73 m2 before the informed consent acquisition 2. Patients whose hepatic function was over 3 times higher than normal upper limit within three months before the informed consent acquisition 3. Patients whose HbA1c was more than 8.0 within three months before the informed consent acquisition 4. Patients received hospitalizing by onset of cardiovascular disease, myocardial infarction, cerebral apoplexy, cardiac insufficiency within six months before the informed consent acquisition 5. Patients complicated angina pectoris, cardiac insufficiency with NYHA 3 or greater at the informed consent acquisition 6. Patients who is already prescribed diuretic or Ca antagonist at the informed consent acquisition 7. Patients with poor feeding 8. Patients of remarkable emaciation 9. Patients complicated with nephrotic syndrome 10. Patients judged unsuitable by physician in charge

发起方

agoya University CKD Clinical Cooperation System Study Group